Still, our results also demonstrate a substantial reduction in Cx43 mRNA levels upon Stat3 inhibition, pointing to a transcriptional effect of Stat3 upon the Cx43 promotor in these NSCLC lines, as previously demonstrated in other cell types[28,40,41]. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.